ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Cullinan Therapeutics Inc

Cullinan Therapeutics Inc (CGEM)

12.02
-0.88
(-6.82%)
Closed 28 December 8:00AM
12.02
-0.01
(-0.08%)
After Hours: 10:56AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
12.02
Bid
11.50
Offer
17.50
Volume
1,899,612
11.81 Day's Range 12.88
9.55 52 Week Range 30.1886
Market Cap
Previous Close
12.90
Open
12.88
Last Trade
22
@
12.02
Last Trade Time
Financial Volume
US$ 22,979,487
VWAP
12.0969
Average Volume (3m)
489,827
Shares Outstanding
58,227,593
Dividend Yield
-
PE Ratio
-4.57
Earnings Per Share (EPS)
-2.63
Revenue
-
Net Profit
-153.16M

About Cullinan Therapeutics Inc

Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Cullinan Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CGEM. The last closing price for Cullinan Therapeutics was US$12.90. Over the last year, Cullinan Therapeutics shares have traded in a share price range of US$ 9.55 to US$ 30.1886.

Cullinan Therapeutics currently has 58,227,593 shares in issue. The market capitalisation of Cullinan Therapeutics is US$751.14 million. Cullinan Therapeutics has a price to earnings ratio (PE ratio) of -4.57.

CGEM Latest News

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024

Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune diseases Cullinan will share details of global...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.1510.579576816910.8712.9510.7862292212.10766387CS
4-1.39-10.36539895613.4113.7810.4453313412.25181866CS
12-4.34-26.528117359416.3617.97510.4448982714.19914974CS
26-4.52-27.327690447416.5421.0110.4457937016.37523501CS
522.3424.1735537199.6830.18869.5562386818.30656774CS
156-4.64-27.851140456216.6630.18867.337624215.15318939CS
260-29.98-71.3809523814259.857.334888217.87789641CS

CGEM - Frequently Asked Questions (FAQ)

What is the current Cullinan Therapeutics share price?
The current share price of Cullinan Therapeutics is US$ 12.02
How many Cullinan Therapeutics shares are in issue?
Cullinan Therapeutics has 58,227,593 shares in issue
What is the market cap of Cullinan Therapeutics?
The market capitalisation of Cullinan Therapeutics is USD 751.14M
What is the 1 year trading range for Cullinan Therapeutics share price?
Cullinan Therapeutics has traded in the range of US$ 9.55 to US$ 30.1886 during the past year
What is the PE ratio of Cullinan Therapeutics?
The price to earnings ratio of Cullinan Therapeutics is -4.57
What is the reporting currency for Cullinan Therapeutics?
Cullinan Therapeutics reports financial results in USD
What is the latest annual profit for Cullinan Therapeutics?
The latest annual profit of Cullinan Therapeutics is USD -153.16M
What is the registered address of Cullinan Therapeutics?
The registered address for Cullinan Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Cullinan Therapeutics website address?
The website address for Cullinan Therapeutics is www.cullinantherapeutics.com
Which industry sector does Cullinan Therapeutics operate in?
Cullinan Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
INTZIntrusion Inc
US$ 2.167
(381.56%)
189.59M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
HUBCWHub Cyber Security Ltd
US$ 0.035
(250.00%)
2.79M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.94M
LITMSnow Lake Resources Ltd
US$ 1.61
(82.95%)
131.96M
NEUPNeuphoria Therapeutics Inc
US$ 4.11
(-92.30%)
940.73k
VIRXViracta Therapeutics Inc
US$ 0.16
(-32.49%)
9.47M
PRFXPainReform Ltd
US$ 3.48
(-28.98%)
949.52k
AIREreAlpha Tech Corporation
US$ 2.56
(-28.49%)
8.42M
AVGRAvinger Inc
US$ 0.9721
(-24.05%)
2.16M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.94M
RGTIRigetti Computing Inc
US$ 17.08
(10.62%)
305.78M
XTIAXTI Aerospace Inc
US$ 0.03935
(-1.63%)
267.99M
QSIQuantum Si Inc
US$ 3.585
(66.74%)
256.01M

Your Recent History

Delayed Upgrade Clock